Could a One-Week radiation course be just as good as three weeks for breast cancer?

NCT ID NCT07274800

Completed Disease control Sponsor: Zagazig University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested whether a shorter, more intense course of radiation (1 week) works as well as the standard 3-week course for women with early breast cancer after lumpectomy. Sixty women were split into two groups to compare side effects, cosmetic results, and cancer control over 24 months. The goal is to see if the quicker schedule can be a safe and convenient alternative.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Radiotherapy (ultra-hypofractionated vs. hypofractionated)
What this could lead to: If the shorter 1-week schedule proves as safe and effective as the 3-week schedule, it could offer a more convenient treatment option for early breast cancer patients.
What could go wrong: This is a small, single-center study with only 60 participants, so results may not apply to all patients. The shorter schedule might increase side effects or reduce cancer control, but the study aims to compare these outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast adenocarcinoma breast cancer breast neoplasm invasive breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Zagazig University

Zagazig, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.